BioCryst Pharmaceuticals' ORLADEYO® Approved for National Reimbursement in the Netherlands for HAE Prevention
6/6 13:11
BioCryst Pharmaceuticals announces ORLADEYO® approval for HAE prevention in the Netherlands, expanding European access to the first oral therapy....